COVID-19 vaccine delivery poses unprecedented challenges in terms of delivery volume, reaching new target populations, and diversity of delivery strategies. Meanwhile, what it costs to deliver these vaccines is highly uncertain. To address this knowledge gap, ThinkWell, in collaboration with its partners and with support from the Bill & Melinda Gates Foundation, produced cost evidence in seven low- and middle-income countries: Bangladesh, Côte d’Ivoire, the Democratic Republic of the Congo (DRC), Mozambique, the Philippines, Uganda, and Vietnam.
This study protocol describes the generalized approach for these studies and discusses the studies’ scope and methods, and expected outputs. While recognizing that the diverse range of vaccine roll-out modalities will require tailored research approaches in each of the countries, this general research protocol is aimed at ensuring comparability across countries and facilitating cross-country learnings.
